Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
72.1M
-
Number of holders
-
37
-
Total 13F shares, excl. options
-
8.21M
-
Shares change
-
-1.67M
-
Total reported value, excl. options
-
$26.6M
-
Value change
-
-$5.12M
-
Number of buys
-
18
-
Number of sells
-
-18
-
Price
-
$3.24
Significant Holders of Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) as of Q3 2019
43 filings reported holding OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share as of Q3 2019.
Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) has 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.21M shares
of 72.1M outstanding shares and own 11.39% of the company stock.
Largest 10 shareholders include BVF INC/IL (2.32M shares), VANGUARD GROUP INC (1.06M shares), CHI Advisors LLC (727K shares), RENAISSANCE TECHNOLOGIES LLC (587K shares), WELLS FARGO & COMPANY/MN (422K shares), Tekla Capital Management LLC (373K shares), Granite Point Capital Management, L.P. (348K shares), AWH Capital, L.P. (260K shares), ACADIAN ASSET MANAGEMENT LLC (233K shares), and GEODE CAPITAL MANAGEMENT, LLC (227K shares).
This table shows the top 37 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.